Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Tasly Pharmaceutical Group Co., Ltd

Market Cap 20.72B 3.05B 2.68B 2.47B 2.31B 4.33B 289B 4.42B 29.68B 11.46B 142B 11.47B 11.22B 493B P/E 2026 *
15.6x
P/E 2027 * 13.1x
Enterprise Value 18.46B 2.72B 2.39B 2.2B 2.06B 3.86B 258B 3.94B 26.44B 10.21B 126B 10.22B 9.99B 440B EV / Sales 2026 *
2.05x
EV / Sales 2027 * 1.84x
Free-Float
46.34%
Yield 2026 *
2.9%
Yield 2027 * 3.63%
1 day+1.31%
1 week-4.54%
Current month-1.42%
1 month-2.26%
3 months-1.98%
6 months-9.11%
Current year-7.96%
1 week 13.38
Extreme 13.38
14.21
1 month 13.38
Extreme 13.38
14.6
Current year 13.38
Extreme 13.38
15.49
1 year 13.38
Extreme 13.38
17.69
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 2024-05-07
Director of Finance/CFO 49 2018-07-08
Chief Investment Officer 45 2025-04-30
Director TitleAgeSince
Director/Board Member 58 2024-03-31
Director/Board Member 62 2007-08-16
Director/Board Member 72 2021-06-01
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%-4.54%-10.52%-1.77% 3.02B
-0.27%-3.23%-11.81%-7.30% 12.82B
+0.25%-4.91%-34.40%-56.50% 4.77B
0.00%-7.65%-13.37%-4.03% 4.3B
-0.05%-2.58%+15.65%-15.43% 3.78B
+2.59%-3.08%+11.00%-39.78% 3.71B
+1.44%-3.15%-4.64%-7.64% 3.5B
+1.26%-1.54%-3.95%-24.18% 2.35B
+0.45%-4.58%-12.23%+31.71% 1.66B
+2.43%-3.50%-11.34%-14.33% 1.62B
Average +0.94%-2.13%-7.56%-13.92% 4.15B
Weighted average by Cap. +0.57%-2.06%-8.88%-15.55%

Financials

2026 *2027 *
Net sales 9B 1.33B 1.16B 1.07B 1B 1.88B 126B 1.92B 12.88B 4.97B 61.46B 4.98B 4.87B 214B 9.87B 1.45B 1.28B 1.18B 1.1B 2.06B 138B 2.1B 14.14B 5.46B 67.44B 5.46B 5.34B 235B
Net income 1.33B 196M 172M 158M 148M 277M 18.53B 283M 1.9B 734M 9.07B 734M 718M 31.59B 1.59B 234M 205M 189M 177M 332M 22.15B 338M 2.27B 877M 10.84B 878M 859M 37.77B
Net Debt -2.26B -333M -292M -269M -252M -472M -31.52B -481M -3.23B -1.25B -15.42B -1.25B -1.22B -53.75B -2.58B -380M -333M -307M -287M -538M -35.95B -549M -3.69B -1.42B -17.59B -1.42B -1.39B -61.31B
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
26-06-23 CN¥13.87 +1.31% 12,476,799
26-06-22 CN¥13.69 -2.84% 17,387,076
26-06-18 CN¥14.09 -0.07% 6,295,319
26-06-17 CN¥14.10 -0.77% 5,621,452
26-06-16 CN¥14.21 -2.20% 7,621,471
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
13.87CNY
Average target price
17.18CNY
Spread / Average Target
+23.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!